|
SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain. |
| |
|
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen |
Speakers' Bureau - Astellas Pharma; Astellas Pharma; Bayer; Bristol-Myers Squibb/Pfizer; Ipsen; Janssen; MSD; Pfizer |
Travel, Accommodations, Expenses - Janssen; Pierre Fabre |
| |
|
Honoraria - Astellas Pharma; Bayer; Eisai; EUSA Pharma; Ipsen; Janssen; Merck; Pfizer |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen |
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Merck |
| |
|
Employment - GlaxoSmithKline (I); Leo P (I) |
Honoraria - Bayer; Bristol-Myers Squibb; Eisai Europe; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Pfizer |
Speakers' Bureau - AAA/Endocyte/Novartis; Bristol-Myers Squibb; Ipsen; Merck |
Research Funding - Janssen Oncology (Inst) |
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer; Roche |
Other Relationship - LEO Pharma (I) |
| |
|
Consulting or Advisory Role - AstraZeneca; Bayer; Merck/Pfizer; Pfizer |
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche |
| |
|
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; BMSi; Pfizer |
Speakers' Bureau - BMSi; Ipsen; Janssen; Novocure; Pfizer |
| |
|
Consulting or Advisory Role - Astellas Pharma; BMS; Ipsen; Janssen Oncology; Merck; MSD; Novartis; Pfizer; Roche |
Speakers' Bureau - Astellas Pharma; BMS; IPSEN; Merck; MSD; Pfizer; Roche |
Travel, Accommodations, Expenses - Ipsen; Merck; Pfizer; Roche |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Ipsen; Sanofi |
Consulting or Advisory Role - Bristol-Myers Squibb; Sanofi |
Speakers' Bureau - Sanofi |
Travel, Accommodations, Expenses - Ipsen |
| |
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi |
Research Funding - Astellas Pharma; Pfizer; Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Merck Serono; MSD Oncology; Pfizer; Roche |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Janssen; Merck; Roche |
| |
|
Honoraria - AstraZeneca; Novartis; Orion; Pfizer |
Consulting or Advisory Role - Ipsen; Novartis; Orion |
| |
|
Consulting or Advisory Role - AstraZeneca; BMS; Boehringer Ingelheim; Eisai; EUSA Pharma; EUSA Pharma; Ipsen; MSD; Pfizer; Roche |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Ipsen; Janssen-Cilag; Janssen-Cilag; Lilly; MSD; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - AstraZeneca; BMS; Lilly; MSD; Pfizer; Roche |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; Roche; Sanofi |
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Eisai; EUSA Pharma; Merck; MSD; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Ipsen; Janssen Oncology; MSD Oncology; Roche |
| |
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb/Celgene; Ipsen; Merck Serono; Pfizer; PharmaMar; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; BMS GmbH & Co. KG; Merck Serono; Pfizer |
Research Funding - Bristol-Myers Squibb/Celgene (Inst); MSD Oncology (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Ipsen; Merck Serono; MSD Oncology; Pfizer; PharmaMar; Roche |